Research Resources
Peptide Research Guides
Clear, UK-focused answers on peptide law, supplier legitimacy and buying for laboratory research. Written for researchers, not patients.
Featured · Definitive guide
UK Peptides Legality Guide (2026)
The full legal picture — MHRA rules, controlled-drug status, GLP-1s, BPC-157, imports, sport and 12 FAQ answers.
Are Peptides Legal in the UK?
Peptides occupy a specific legal space in the UK. In short: most research peptides are legal to buy, sell and possess for laboratory research, but they are not licensed medicines and cannot be sold for human use. This guide explains exactly what that means in practice.
Is UK Peptides Legit? How to Spot a Trustworthy UK Supplier
'Is UK Peptides legit?' is one of the most common questions researchers ask before placing a first order. There are several UK-based suppliers using similar names, and quality varies widely. Here's the checklist we recommend before buying from anyone — including us.
Where to Buy Peptides in the UK (2026 Guide)
If you're searching for where to buy peptides in the UK, the choice essentially comes down to two routes: a UK-based supplier shipping domestically, or an overseas vendor shipping through customs. Both are used, but they carry very different practical risks.
Are Peptides Illegal in the UK?
Peptides are not illegal in the UK as a class of substance. What makes any specific transaction legal or illegal is who it's for and how it's marketed. This guide breaks down the distinction.
BPC-157 — UK Research Guide (2026)
BPC-157 is one of the most-requested research peptides in the UK. This guide covers the practical specifics — purity, reconstitution, storage and how UK-based suppliers like Professor Peptide handle batch testing.
Retatrutide vs Tirzepatide vs Semaglutide — Research Comparison
Three GLP-1-class compounds dominate metabolic peptide research right now. This is a strictly in-vitro / pharmacology-focused comparison — not dosing or human-use advice.
How to Reconstitute Peptides — UK Research Guide
Reconstitution turns a lyophilised research peptide into a liquid for downstream in-vitro assays. The procedure is simple but sterility and accurate volume measurement matter.
Retatrutide vs Tirzepatide: UK Research Comparison
Retatrutide and Tirzepatide are the two most discussed incretin research peptides in the UK laboratory community. Both target GLP-1 signalling, but their receptor profiles — and the trial data behind them — are meaningfully different. This guide compares the two side by side for research reference.
Retatrutide vs Semaglutide: UK Research Comparison
Short answer: retatrutide shows the larger effect in published trials — 24.2% mean body-weight reduction at 48 weeks against semaglutide's 14.9% at 68 weeks — while semaglutide has the deeper safety and cardiovascular evidence base. Below we compare the two side by side on mechanism, trial data, weekly dosing and UK research supply, so you can pick the right vial for your protocol.
Tirzepatide vs Semaglutide: UK Research Comparison
Tirzepatide and Semaglutide dominate the UK research-peptide market. Both are once-weekly incretin analogues, but their receptor profiles and trial results differ in ways that matter for study design. Here is a plain comparison.
Retatrutide vs Tirzepatide: Triple Agonist vs Dual Agonist Research Comparison
Retatrutide and Tirzepatide are the two most closely followed incretin-class research peptides in UK laboratories. The comparison usually comes down to one distinction: triple agonist versus dual agonist. This guide compares their receptor binding, in-vitro pharmacology profiles and practical research handling — strictly for laboratory reference, not human use.